PET/MRI Perfusion and CT Perfusion in Solid Tumors (Perfusion)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Diagnostic comparison between PET/CT and PET/MRI with integrated perfusion measurement in CT and MR. Study aim is to gain knowledge about additional value of CT perfusion and MR perfusion in solid tumors concerning tumor physiology, diagnostic accuracy and possibly prognostic.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
30 Years to 90 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT
indication as stated above
written informed consent
patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT
pregnant or breast feeding women
non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)
Inclusion in another clinical trial 30 days prior to inclusion
age < 30years
contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia
known allergies to contrast CT or MRI contrast media
patients with an glomerular filtration rate of < 60ml/min/1.73m2